ProSci Incorporated is a privately-held biotechnology firm located in San Diego, California doing business for over 20 years. A leader in its field, ProSci’s priority is to provide the highest quality monoclonal, polyclonal, and recombinant antibody products and services in the industry. ProSci’s expertise in antibody development, production, and biological research is realized through customizable services, innovative products, competitive pricing, high-quality research tools, and unparalleled technical support.
ProSci Incorporated specializes in the production of affinity-purified peptide-specific polyclonal antibodies to novel antigens in fields such as HIV. To date, ProSci has an antibody catalog of over 30,000 primary antibodies. Many of the polyclonal research antibodies offered by ProSci are affinity-purified, which allows for the isolation of antibodies specific to the epitope of interest. As a result, ProSci's antibodies have the same specificity as monoclonal antibodies. In addition, ProSci offers a complete assortment of reagents for immunochemical assays, including cell line lysates, tissue lysates and peptides as controls for these antibodies.
ProSci’s research programs include cancer biomarker discovery and neutralizing antibody development against emergent viruses such as SARS-CoV-2, HIV, and influenza. ProSci’s innovative research approach using genetically engineered yeast strain and glycoproteins to mimic the HIV-1 glycan coat and develop neutralizing antibodies against HIV-1 glycans has been awarded several Small Business Innovative Research (SBIR) grants by NIH. Its research projects have resulted in an invention patent granted by the U.S. Patent and Trademark Office, and a number of peer-reviewed publications.
ProSci’s custom antibody services specialize in polyclonal, monoclonal, and recombinant rabbit monoclonal and recombinant llama single domain antibody development and production. ProSci has customizable services that include antigen design, peptide synthesis, protein conjugation, antibody development and production … and more. Being in business over 20 years, completing over 20,000 individual antibody projects, and having in-house research programs allows ProSci the experience to work closely with researchers globally to deliver antibodies which meet their needs and further scientific success.
For more information regarding our custom services, visit our services website.
ProSci supports the responsible and ethical use of animals in order to advance medical science and improve the health of both humans and animals. We recognize animal care is a subject of ethical concern and strive to ensure the humane and responsible treatment of all animals in connection with our research. At this time, antibodies are essential and indispensable to the discovery and development of innovative therapeutic drugs, diagnostic kits, and prophylactic vaccines, all of which are crucial for preventing and curing disease, including cancer and AIDS. However, ProSci continues to work toward the development of new recombinant antibodies produced via laboratory methods, which reduce the need for animal-derived products.